[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100493013":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":18,"responsibleParty":34,"collaborators":36,"id":46,"slug":47,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":7,"eligibilityCriteria":52,"healthyVolunteers":53,"sex":54,"minAge":55,"maxAge":7,"enrollmentInfo":56,"targetDuration":7,"studyType":59,"phases":7,"briefSummary":60,"conditions":61,"keywords":7,"overallStatus":20,"whyStopped":7,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":73},{"fullName":5,"class":6},"Shandong First Medical University","OTHER",null,[9],{"name":10,"affiliation":5,"role":11},"Tao Xu, Dr.","STUDY_CHAIR",[13],{"name":14,"role":15,"phone":16,"phoneExt":7,"email":17},"Rong Huang, Dr.","CONTACT","18854125717","huangrong9277@163.com",[19],{"facility":5,"status":20,"city":21,"state":22,"zip":23,"country":24,"countryCode":25,"cosmosGeoPoint":26,"geoPoint":31,"contacts":32},"RECRUITING","Jinan","Shandong","277500","China","CN",{"type":27,"coordinates":28},"Point",[29,30],116.99722,36.66833,{"lat":30,"lon":29},[33],{"name":14,"role":15,"phone":7,"phoneExt":7,"email":7},{"type":35,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR",[37,39,42,44],{"name":38,"class":6},"Jinan Central Hospital",{"name":40,"class":41},"Shandong Provincial Hospital","OTHER_GOV",{"name":43,"class":6},"The Second Affiliated Hospital of Shandong First Medical University",{"name":45,"class":6},"Qianfoshan Hospital","100493013","prospective-coronary-heart-disease-cohort-100493013",false,"NCT05699629","Prospective Coronary Heart Disease Cohort","A Prospective Longitudinal Multi-Omics Cohort of Patients With Coronary Heart Disease Undergoing Coronary Angiography","Inclusion Criteria:\n\n* Diagnosed as coronary heart disease or with unexplained chest pain needed to undergo coronary angiography.\n* Healthy subjects undergoing routine physical examination in the physical examination department and willing to sign informed consent will be recruited as control subjects.\n\nExclusion Criteria:\n\n* With malignant tumors, infectious diseases and advanced liver diseases.\n* Won't sign an inform consent.",true,"ALL","18 Years",{"count":57,"type":58},50000,"ESTIMATED","OBSERVATIONAL","To evaluate the biomarkers for the prognosis of coronary heart disease, patients with coronary heart disease will be recruited and followed up for at least 2 years.",[62,63],"Coronary Heart Disease","Myocardial Infarction","2023-02-09",{"date":66,"type":67},"2023-02-13","ACTUAL",{"date":69,"type":67},"2022-01-21",{"date":71,"type":58},"2027-01-21",{"name":5,"class":6},1]